With great pleasure, DiaSys India announces the completion of three successful years. During this short journey, the company has made memorable and notable accomplishments in the backdrop of very challenging economic environment in our country.
Shifting manufacturing unit to spacious, state-of-the-art Mahape premises in March 2017 shows the commitment for providing high quality indigenous products. DiaSys India has launched many exciting products during these three glorious years and improved services in a bid to strive for perfection in every domain. It registered close to 20 per cent annual sales growth over last year. The company employs 180+ employees in different functions located at various geographical locations.
The company said, “Thanks to all our distributors who stood with us at all times, gave us constructive feedback and remained committed to our aggressive growth plans.”
Road map ahead
Increased awareness amongst people, high percentage of affordable population, reimbursements by insurance companies, exponential jump in life style related ailments has made IVD industry rise rapidly.
The company has listed key enablers for meeting ambitious, comprehensive agenda for strengthening our position in Indian market:
- DiaSys India now takes this opportunity to announce launch of its newest and most exciting systems in DiaSys India product portfolio – 3 part (respons r3H) and 5 part (respons r5H) differential haematology analyser. With this launch, the company has announced its foray in haematology segment.
- Innovative technological advancements are rapidly changing healthcare landscape. DiaSys India proudly boast existence of research and development centre in
India. - DiaSys India RnD is fostering innovation and is set to launch in-house developed product range starting with Electrolyte analyser by third quarter of this year.
- The art of diagnostics is infinitely creative and it inspires us to continuously improve quality of the products. Through regular investments and employing skilled manpower, DiaSys India seeks to accelerate the introduction of processes, technologies, and regulations required to continuously roll out high quality products from its manufacturing unit located in Mahape.
- This is also helping DiaSys India build sustainability into its products and operations. The company is adding 45 new employees in DiaSys family for strengthening all our company functions.
- DiaSys India Urine portfolio, Rapids, POC are set for higher growths this year through focussed approach and dedicated resources for doctor clinics in tier II and tier III cities. This will help doctors offer right and quality treatment to needy patients on time.
- DiaSys India completely understands the dynamic nature of systems in labs. Customer needs systems to be functional round the clock to meet normal and emergency workload of patients. The company has decided to improve after sales service as satisfied customers will help it in brand building and profit generation. A lot of emphasis is being given to recruitment and technical training of engineers this year.
With our expertise and experience, we are clear on:
Arenas:
- Where will we be active geographically and product wise?
- Who will be our core customers and what it takes for us to retain them?
Differentiators:
- What different will we do from our competitors?
- How will we win?
In short, with right blend of products and aggressive people, DiaSys India has embarked on an exciting journey with passionate commitment for profitable growth and giving paramount importance to customer satisfaction and patients’ welfare in India.
- Advertisement -
Comments are closed.